Covered recipient · General Payments record
HEATHER LINNEA SARAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$14,220.29
- Reported across 478 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,244.34 | 119 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $421.30 | 9 |
| Corcept Therapeutics | $305.21 | 4 |
| Rhythm Pharmaceuticals, Inc. | $254.79 | 3 |
| Lilly USA, LLC | $208.82 | 16 |
| Xeris Pharmaceuticals, Inc. | $201.43 | 5 |
| Medtronic, Inc. | $201.02 | 6 |
| ABBVIE INC. | $185.22 | 12 |
| Insulet Corporation | $167.02 | 8 |
| BIOTRONIK NRO, Inc. | $156.89 | 1 |
| BETA BIONICS, INC. | $140.62 | 13 |
| MAYNE PHARMA COMMERCIAL LLC | $121.82 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $88.22 | 3 |
| MannKind Corporation | $82.38 | 4 |
| Radius Health, Inc. | $76.71 | 4 |
| SANOFI-AVENTIS U.S. LLC | $66.09 | 3 |
| Abbott Laboratories | $65.80 | 3 |
| Amgen Inc. | $59.85 | 4 |
| CeQur Corporation | $50.14 | 1 |
| Novo Nordisk AS | $49.70 | 2 |
| Kyowa Kirin, Inc. | $42.89 | 2 |
| Tandem Diabetes Care, Inc. | $41.99 | 1 |
| Verity Pharmaceuticals Inc. | $40.00 | 2 |
| PFIZER INC. | $35.95 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.72 | 2 |
| Neurocrine BioSciences, Inc. | $35.17 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $35.14 | 2 |
| TOLMAR, INC. | $28.68 | 2 |
| Amphastar Pharmaceuticals, Inc. | $18.29 | 1 |
| Ascendis Pharma Inc | $13.89 | 1 |
| CHIESI USA, INC. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (119)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.